Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365482011> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4365482011 endingPage "27" @default.
- W4365482011 startingPage "27" @default.
- W4365482011 abstract "Nonalcoholic fatty liver disease (NAFLD) is a common obesity-related disease. In this study, we aimed to investigate the effects of pioglitazone on NAFLD in morbid obese patients.This is a randomized controlled trial study that was performed in 2020-2021 on 44 patients who had grade 3 NAFLD. At the beginning of the study, we collected the following data: age, gender, body mass index (BMI), fasting blood glucose (FBS), lipid profile, aspartate aminotransferase, alanine aminotransferase (ALT), and the total size and volume of the liver and the left lobe of the liver. Patients in the control group were given a special diet. For patients in the treatment group, pioglitazone 15 mg tablets were administered twice daily for 4 months.At the beginning of the study, all patients in both groups had grade 3 of NAFLD. After the treatments, 50% of the pioglitazone group had grade 1 NAFLD, and 50% of other patients had grade 2 that showed significant improvements in patients (P < 0.001). We also found significant improvements in the following items in the intervention group: liver size (P < 0.001), size of the left liver lobe (P < 0.001), FBS (P = 0.036), ALT (P = 0.011), and BMI (P < 0.001). No significant improvements were found in the control group (P > 0.05).The use of pioglitazone for 4 months resulted in improvements in fatty liver stage, liver size, BMI, FBS, and lipid profile. These data show the effectiveness of pioglitazone in NAFLD." @default.
- W4365482011 created "2023-04-15" @default.
- W4365482011 creator A5013203147 @default.
- W4365482011 creator A5023991054 @default.
- W4365482011 creator A5034851576 @default.
- W4365482011 creator A5035981845 @default.
- W4365482011 creator A5040548759 @default.
- W4365482011 date "2023-01-01" @default.
- W4365482011 modified "2023-10-17" @default.
- W4365482011 title "Effect of Pioglitazone on Nonalcoholic Fatty Liver Disease in Morbid Obese Patients; a Randomized Controlled Trial." @default.
- W4365482011 cites W1921835937 @default.
- W4365482011 cites W2294346279 @default.
- W4365482011 cites W2619337392 @default.
- W4365482011 cites W2742155329 @default.
- W4365482011 cites W2749053350 @default.
- W4365482011 cites W2762967301 @default.
- W4365482011 cites W2795554754 @default.
- W4365482011 cites W2810423511 @default.
- W4365482011 cites W2951753379 @default.
- W4365482011 cites W2969688211 @default.
- W4365482011 cites W3003178805 @default.
- W4365482011 cites W3003750415 @default.
- W4365482011 cites W3026456853 @default.
- W4365482011 cites W3030999317 @default.
- W4365482011 cites W3111625382 @default.
- W4365482011 cites W3146345234 @default.
- W4365482011 cites W3158749710 @default.
- W4365482011 cites W3161674598 @default.
- W4365482011 cites W4241721607 @default.
- W4365482011 doi "https://doi.org/10.4103/abr.abr_354_21" @default.
- W4365482011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37057246" @default.
- W4365482011 hasPublicationYear "2023" @default.
- W4365482011 type Work @default.
- W4365482011 citedByCount "1" @default.
- W4365482011 countsByYear W43654820112023 @default.
- W4365482011 crossrefType "journal-article" @default.
- W4365482011 hasAuthorship W4365482011A5013203147 @default.
- W4365482011 hasAuthorship W4365482011A5023991054 @default.
- W4365482011 hasAuthorship W4365482011A5034851576 @default.
- W4365482011 hasAuthorship W4365482011A5035981845 @default.
- W4365482011 hasAuthorship W4365482011A5040548759 @default.
- W4365482011 hasConcept C126322002 @default.
- W4365482011 hasConcept C134018914 @default.
- W4365482011 hasConcept C168563851 @default.
- W4365482011 hasConcept C2776954865 @default.
- W4365482011 hasConcept C2777180221 @default.
- W4365482011 hasConcept C2778163477 @default.
- W4365482011 hasConcept C2778270857 @default.
- W4365482011 hasConcept C2778384471 @default.
- W4365482011 hasConcept C2778772119 @default.
- W4365482011 hasConcept C2779134260 @default.
- W4365482011 hasConcept C2780221984 @default.
- W4365482011 hasConcept C555293320 @default.
- W4365482011 hasConcept C71924100 @default.
- W4365482011 hasConcept C90924648 @default.
- W4365482011 hasConceptScore W4365482011C126322002 @default.
- W4365482011 hasConceptScore W4365482011C134018914 @default.
- W4365482011 hasConceptScore W4365482011C168563851 @default.
- W4365482011 hasConceptScore W4365482011C2776954865 @default.
- W4365482011 hasConceptScore W4365482011C2777180221 @default.
- W4365482011 hasConceptScore W4365482011C2778163477 @default.
- W4365482011 hasConceptScore W4365482011C2778270857 @default.
- W4365482011 hasConceptScore W4365482011C2778384471 @default.
- W4365482011 hasConceptScore W4365482011C2778772119 @default.
- W4365482011 hasConceptScore W4365482011C2779134260 @default.
- W4365482011 hasConceptScore W4365482011C2780221984 @default.
- W4365482011 hasConceptScore W4365482011C555293320 @default.
- W4365482011 hasConceptScore W4365482011C71924100 @default.
- W4365482011 hasConceptScore W4365482011C90924648 @default.
- W4365482011 hasLocation W43654820111 @default.
- W4365482011 hasOpenAccess W4365482011 @default.
- W4365482011 hasPrimaryLocation W43654820111 @default.
- W4365482011 hasRelatedWork W2033522292 @default.
- W4365482011 hasRelatedWork W2042938358 @default.
- W4365482011 hasRelatedWork W2134384860 @default.
- W4365482011 hasRelatedWork W2163547766 @default.
- W4365482011 hasRelatedWork W2378305554 @default.
- W4365482011 hasRelatedWork W2516295949 @default.
- W4365482011 hasRelatedWork W2900203900 @default.
- W4365482011 hasRelatedWork W2985782618 @default.
- W4365482011 hasRelatedWork W2991362750 @default.
- W4365482011 hasRelatedWork W8919293 @default.
- W4365482011 hasVolume "12" @default.
- W4365482011 isParatext "false" @default.
- W4365482011 isRetracted "false" @default.
- W4365482011 workType "article" @default.